Scribe Therapeutics
$15.42
7
-$2.02-11.58%Friday 20:00
-$0.17-1.1%Friday 23:55After hours
Statistics
Day High
15.53
Day Low
15.4
52W High
39.6
52W Low
13.5
Volume
10,683
Avg. Volume
-
Mkt Cap
291.93M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q2 2026
Next
-3.62
-2.7
-1.78
-0.85
Expected EPS
-0.8539
Actual EPS
N/A
Financials
-42.62%Profit Margin
Unprofitable51.17MRevenue
-21.81MNet Income
Analyst Ratings
$51.75Average Price Target
The highest estimate is 60.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SCTX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Show More
CEO
Benjamin L. Oakes
Employees
89
Country
United States
ISIN
US8110331092
Listings
0 Comments
Share your thoughts
FAQs
What is Scribe Therapeutics stock price today?▼
The current price of SCTX is $15.42 USD — it has decreased by -11.58% in the past 24 hours. Watch Scribe Therapeutics stock price performance more closely on the chart.
What is Scribe Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Scribe Therapeutics stocks are traded under the ticker SCTX.
What is Scribe Therapeutics market cap?▼
Today Scribe Therapeutics has the market capitalization of 291.93M
When is the next Scribe Therapeutics earnings date?▼
Scribe Therapeutics is going to release the next earnings report on December 2, 2026.
What were Scribe Therapeutics earnings last quarter?▼
SCTX earnings for the last quarter are -2.62 USD per share, whereas the estimation was -3.62 USD resulting in a +27.58% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Scribe Therapeutics revenue for the last year?▼
Scribe Therapeutics revenue for the last year amounts to 51.17M USD.
What is Scribe Therapeutics net income for the last year?▼
SCTX net income for the last year is -21.81M USD.
How many employees does Scribe Therapeutics have?▼
As of November 1, 2026, the company has 89 employees.
In which sector is Scribe Therapeutics located?▼
Scribe Therapeutics operates in the Health & Wellness sector.
When did Scribe Therapeutics complete a stock split?▼
Scribe Therapeutics has not had any recent stock splits.
Where is Scribe Therapeutics headquartered?▼
Scribe Therapeutics is headquartered in ALAMEDA, United States.